Background: Minimal hepatic encephalopathy, defined by the portosystemic hepatic encephalopathy score (PHES), is associated with a higher risk of subsequent OHE. It remains unclear if there is a stepwise increase in OHE risk with worse PHES results. Methods: In this multicenter study, patients with minimal hepatic encephalopathy, as defined by abnormal PHES, were followed for OHE development. Results: In all, 207 patients were included. There was no stepwise increase in OHE risk with worse PHES results. Conclusions: Abnormal PHES is associated with a higher OHE risk, but we found no stepwise increase in OHE risk with worse PHES results below the established cutoff. 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.
PHES scores have limited impact on the risk of overt HE in patients with minimal HE / Gairing, S.J., Mangini, C., Zarantonello, L., Jonasson, E., Danneberg, S., Sultanik, P., Galle, P.R., Gioia, S., Labenz, J., Lok, A.S., Marquardt, J.U., Lauridsen, M.M., Bloom, P.P., Thabut, D., Nardelli, S., Montagnese, S., Labenz, C.. - In: HEPATOLOGY COMMUNICATIONS. - ISSN 2471-254X. - 8:5(2024). [10.1097/HC9.0000000000000438]
PHES scores have limited impact on the risk of overt HE in patients with minimal HE
Gioia, Stefania;Nardelli, Silvia;
2024
Abstract
Background: Minimal hepatic encephalopathy, defined by the portosystemic hepatic encephalopathy score (PHES), is associated with a higher risk of subsequent OHE. It remains unclear if there is a stepwise increase in OHE risk with worse PHES results. Methods: In this multicenter study, patients with minimal hepatic encephalopathy, as defined by abnormal PHES, were followed for OHE development. Results: In all, 207 patients were included. There was no stepwise increase in OHE risk with worse PHES results. Conclusions: Abnormal PHES is associated with a higher OHE risk, but we found no stepwise increase in OHE risk with worse PHES results below the established cutoff. 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
